Time to antibiotics is unrelated to outcome in pediatric patients with fever in neutropenia presenting without severe disease during chemotherapy for cancer

[1]  M. Ansari,et al.  Predicting fever in neutropenia with safety‐relevant events in children undergoing chemotherapy for cancer: The prospective multicenter SPOG 2015 FN Definition Study , 2021, Pediatric blood & cancer.

[2]  K. Scheinemann,et al.  Predicting Fever in Neutropenia with Safety Relevant Events in Children Undergoing Chemotherapy for Cancer: the Prospective Multicenter SPOG 2015 FN Definition Study , 2021 .

[3]  A. Groll,et al.  8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation. , 2021, The Lancet. Oncology.

[4]  Jenae Roseland.  Improving Antibiotic Timing in Febrile Neutropenia for Pediatric Oncology Patients with a Central Line , 2021, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

[5]  Rachel M. Edwards,et al.  Improving management of fever in neutropenic children with cancer across multiple sites. , 2021, European journal of cancer care.

[6]  A. Simon,et al.  39·0°C versus 38·5°C ear temperature as fever limit in children with neutropenia undergoing chemotherapy for cancer: a multicentre, cluster-randomised, multiple-crossover, non-inferiority trial. , 2020, The Lancet. Child & adolescent health.

[7]  B. Phillips,et al.  Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: a systematic review , 2020, Supportive Care in Cancer.

[8]  B. Phillips,et al.  Interventions aiming to reduce time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN), a systematic review , 2019, Supportive Care in Cancer.

[9]  B. Phillips,et al.  Protocol for a systematic review of time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN) and interventions aiming to reduce TTA , 2019, Systematic Reviews.

[10]  Lisa M. Daniels,et al.  Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia , 2019, Supportive Care in Cancer.

[11]  S. Alexander,et al.  Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  L. Stewart,et al.  Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis , 2016, British Journal of Cancer.

[13]  L. Stewart,et al.  Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis , 2016, British Journal of Cancer.

[14]  D. Simian,et al.  Administration Time for the First Dose of Antimicrobials in Episodes of Fever and Neutropenia in Children With Cancer , 2015, The Pediatric infectious disease journal.

[15]  K. Thursky,et al.  Core outcomes and definitions for pediatric fever and neutropenia research: A consensus statement from an international panel , 2015, Pediatric blood & cancer.

[16]  J. Hilden,et al.  Pediatric patients who receive antibiotics for fever and neutropenia in less than 60 min have decreased intensive care needs , 2015, Pediatric blood & cancer.

[17]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[18]  R. Rosa,et al.  Cohort Study of the Impact of Time to Antibiotic Administration on Mortality in Patients with Febrile Neutropenia , 2014, Antimicrobial Agents and Chemotherapy.

[19]  Song Zhang,et al.  Prompt administration of antibiotics is associated with improved outcomes in febrile neutropenia in children with cancer , 2013, Pediatric blood & cancer.

[20]  M. Caniza,et al.  Low Socioeconomic Status Is Associated with Prolonged Times to Assessment and Treatment, Sepsis and Infectious Death in Pediatric Fever in El Salvador , 2012, PloS one.

[21]  N. Winick,et al.  Time‐to‐antibiotic administration as a quality of care measure in children with febrile neutropenia: A survey of pediatric oncology centers , 2012, Pediatric blood & cancer.

[22]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[23]  S. Thiel,et al.  Serum concentrations of lectin‐pathway components in healthy neonates, children and adults: mannan‐binding lectin (MBL), M‐, L‐, and H‐ficolin, and MBL‐associated serine protease‐2 (MASP‐2) , 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[24]  K. Sepkowitz,et al.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  A. Simon,et al.  Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  D. Catchpoole,et al.  Respiratory viruses, a common microbiological finding in neutropenic children with fever , 2010, Journal of Clinical Virology.

[27]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[28]  A. Randolph,et al.  International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics* , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[29]  A. Hirt,et al.  Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. , 2003, Medical and pediatric oncology.

[30]  J. Ellis,et al.  Pain Practices: A Cross-Canada Survey of Pediatric Oncology Centers , 2003, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

[31]  Y. S. Sathe,et al.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. , 1966, Annals of internal medicine.

[32]  J. Petit.  Internacional pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics , 2005 .